“tom-hughes” Archives

in
Entry Author Date Location
After Zafgen Abandons Prader-Willi Drug, Could Rhythm Offer Hope? 07/28/16 Boston
Biotech Roundup: Scangos’s Exit, Zafgen’s Shakeup, Jounce, Relypsa & More 07/22/16 National
Zafgen Restructures, Abandons Obesity Drug Following FDA Meeting 07/19/16 Boston
East Coast Biotech Roundup: NY Bio, Gender Gap, Zafgen, PureTech & More 05/12/16 Boston
Some Good News, Finally, for Zafgen’s Obesity Drug 01/20/16 Boston
Zafgen Shares Fall Again as Second Patient Dies in Trial 12/02/15 Boston
After a Clinical Trial Death, Zafgen Presses On, Families Stay Calm 11/23/15 Boston
FDA Puts a Hold on Zafgen’s Obesity Drug, Shares Slide 10/16/15 Boston
After Orexigen Gaffe, What Role for Drugs Amid Obesity Crisis? 05/26/15 National
ZappRx Nabs $5.6M, Inks Zafgen Deal to E-Prescribe Obesity Meds 04/02/15 Boston
Boston’s Life Science Disruptors: The Photos 10/21/14 Boston
Six Takeaways from Boston’s Life Science Disruptors 10/13/14 Boston
Boston VC Firms, Pharmas Team up on $23.5M Series A For Navitor 06/19/14 Boston
Zafgen Hauls In $96M in Upsized IPO 06/18/14 Boston
10 Tips for Maximizing the JP Morgan Healthcare Experience 12/23/13 National
East Coast Life Sciences Roundup: J&J, Celgene, Zafgen, & More 06/28/13 Boston
Zafgen’s Obesity Drug Continues to Cut The Fat in Phase 2 Trial 06/22/13 Boston
If You’ve Got a Real Breakthrough, the FDA Wants To Talk 01/14/13 National
Zafgen Weight Loss Drug Shows Promise in First Human Test 01/05/11 Boston
Tethys Pockets $33M, Achaogen’s Vision for Antibiotics, Genentech Strikes Out at FDA Panel, & More Bay Area Life Sciences News 07/23/10 San Francisco
Lessons Learned About the Outlook for New Obesity Drug Approval 07/16/10 National
Alnara Pharma Used “Flexible” Strategy on Road to Eli Lilly Deal 07/08/10 Boston
Zafgen Grabs $8.1M More in B Round 03/01/10 Boston
Zafgen Plans Weight-Loss Study, Infinity CEO Perkins Plans for Growth, Boston Scientific Cuts 1000+ Jobs, & More Boston-Area Life Sciences News 02/12/10 Boston
Zafgen’s Mysterious Weight Loss Drug Advances Into First Trial for Obese Women 02/08/10 Boston
How to Raise $50M in a Recession: Highlights from the Xconomy Life Sciences Forum 05/01/09 Boston
Harvard Researcher to Helm Merck’s Cancer Research, Genzyme Acquires Certain Exact Sciences Assets, NeurAxon Out to Axe Migraines, & More Boston-Area Life Sciences 02/04/09 Boston
Zafgen’s Big Idea: Fight Fat by Cutting Off Its Blood Supply 01/28/09 Boston
Alnylam Adds Another RNA Approach, Vertex Tackles Hardest Hep C Cases, Zafgen Places Big Bet on Fat Shrinkers, & More Life Sciences News 09/10/08 Boston
Zafgen, Developer of Fat-Shrinking Drugs, Hires Novartis Scientist as New CEO and Emerges From Stealth Mode 09/09/08 Boston
Page 1 of 1